Show
Sort by
-
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis
-
Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination
-
- Journal Article
- A1
- open access
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study
-
- Journal Article
- A1
- open access
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency
-
A novel TLX1-driven T-ALL zebrafish model : comparative genomic analysis with other leukemia models
-
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
-
Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia
-
Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia
-
The NF1 hotspot in acute myeloid leukemia : what’s in a name?
-
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials